Recent Press Coverage: Pharmaphorum – Cementing the Value of Medical Affairs

A number of trends including tougher regulatory controls, increased transparency expectations, an increasingly vocal patient and greater requirements for post-marketing evidence have driven the growth of medical affairs over the years. This changing landscape is placing new demands on the medical affairs function creating a requirement for clearer process and role definition, increased collaboration with other functions including commercial, clinical and R&D, better understanding of the regulatory and compliance environment, and a more effective way of demonstrating the value of activities.

Defining the desired impact for Medical Affairs, deriving metrics associated with those activities, and developing a format for reporting accomplishments to senior management will be essential to demonstrate value. “Showing the value of medical affairs will be very important in that transformation from support function to a strategic partner”, says Charlotte Kremer, Global President of The Medical Affairs Professional Society (MAPS)™, speaking at their annual meeting in Miami in February.



Stay Connected with MAPS

Join MAPS on LinkedIn to further build your professional connections within Medical Affairs through our Company and Group Pages.

Follow us on Twitter and say abreast of MAPS activities and key issues for Medical Affairs professionals.